Written by: Apoorva Kakkilaya Edited by: Esther Melamed On November 17, 2020, the FDA issued its first emergency use authorization (EUA) for a self-test kit that can be administered entirely at home. The Lucira COVID-19 All-In-One Test Kit utilizes RT-LAMP technology to detect SARS-CoV-2 RNA from self-collected nasal swab samples. Swabs are placed in an included test unit and a positive or negative result is displayed within 30 minutes. Data from the manufacturer indicates sensitivity of 94.1% and specificity of 98.0%. Access to this test requires a prescription from a health care provider …